Revapip-TZ combines 400 mg of Piperacillin and 0.5 mg of Tazobactam in a single formulation. This combination antibiotic is effective against a broad range of bacterial infections, offering potent antimicrobial action by enhancing the efficacy of Piperacillin and inhibiting beta-lactamase enzymes that cause resistance.